A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma

A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanomaA patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma, Published online: 24 July 2018; doi:10.1038/s41419-018-0865-6A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma

Source: Cell death and disease - July 24, 2018 Category: Internal Medicine Authors: Berglind O. Einarsdottir Joakim Karlsson Elin M. V. S öderberg Mattias F. Lindberg Elisa Funck-Brentano Henrik Jespersen Siggeir F. Brynjolfsson Roger Olofsson Bagge Louise Carstam Martin Scobie Tobias Koolmeister Olof Wallner Ulrika Stierner Ulrika Warp Source Type: research